Head- Discovery Biology and Toxicology @ Aurigene Pharmaceutical Services Limited (June 2020 - June 2021)
Director, Pre-clinical Safety Evaluation @ (April 2014 - June 2020)
Director and Test Facility Management @ Vanta Bioscience-Kemin (February 2012 - April 2014)
Asst. Director and Head, Rodent Toxicology @ Advinus Therapeutics Limited (currently know as Adgyl life sciences) (April 2007 - January 2012)
Research Scientist @ (June 2004 - April 2007)
Senior Scientist @ (November 1996 - June 2004)
Rajesh Eswarappa Education
The Maharaja Sayajirao University of Baroda
PhD (Toxicology)
Rajesh Eswarappa Skills
Oecd
Project Scope
Pharmaceutical Industry
Drug Development
Pharmaceutics
Clinical Development
CRO
GLP
Sop
Toxicology
In Vitro
In Vivo
Project Scope Development
IND
Pharmacokinetics
Regulatory Submissions
Drug Discovery
Rajesh Eswarappa Summary
Rajesh Eswarappa, based in Hyderabad, IN, is currently a Senior Director, Non-clinical Safety Evaluation-Early Development at Aurigene Oncology Limited. Rajesh Eswarappa brings experience from previous roles at Aurigene Pharmaceutical Services Limited, Aurigene Discovery Technologies, Vanta Bioscience-Kemin and Advinus Therapeutics Limited (currently know as Adgyl life sciences). Rajesh Eswarappa holds a PhD in Toxicology @ The Maharaja Sayajirao University of Baroda. With a robust skill set that includes Oecd, Project Scope, Pharmaceutical Industry, Drug Development, Pharmaceutics and more. Rajesh Eswarappa has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Rajesh Eswarappa?
Find contact details for 700 million professionals.